Winner Category: Science

  • April 23, 2023
    Rising to the Challenges of Rare Disease Treatment Soligenix, Inc. (NASDAQ:SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing…
  • March 30, 2023
    Fathom prides itself on a uniquely quirky brand, targeting large clientele, including insurance companies and governments. However, Fathom suffered from inconsistent brand materials…